In a study conducted by Sun et al., breast cancer patients undergoing Paclitaxel chemotherapy were analyzed, revealing that those with elevated PGK1 expression exhibited shorter overall survival compared to patients with lower PGK1 levels. This evidence concerns the gene PGK1 and breast cancer.